Top 10 Companies in the Squalene Market (2026): Market Leaders Powering Global Growth

MARKET INSIGHTS

Global squalene market size was valued at USD 8.7 million in 2024 and is projected to reach USD 47.9 million by 2032, exhibiting a CAGR of 28.1% during the forecast period. The market is primarily driven by increasing demand from the pharmaceutical and cosmetic industries, with Europe dominating nearly 63% of the global share.

Squalene is a naturally occurring organic compound, primarily sourced from shark liver oil or plant-based alternatives such as olive oil and sugarcane. It serves as a key ingredient in vaccines, pharmaceuticals, and high-end cosmetics due to its antioxidant and emollient properties. The plant‑derived segment currently holds 70% market share, reflecting the industry’s shift toward sustainable sourcing practices.

While vaccines/pharmaceuticals applications account for 51% of total consumption, growth is further propelled by rising health consciousness and premium skincare trends. However, supply chain constraints for shark‑derived squalene pose challenges. Key players like Amyris and Clariant are investing in bioengineered alternatives, with YiChun Dahaigui Life Science, Kishimoto, and EFP collectively controlling 78% of the market through advanced production technologies.

Squalene Market – View in Detailed Research Report

🔟 1. YiChun Dahaigui Life Science

Headquarters: Shanghai, China
Key Offering: Plant‑derived squalene, fermentation‑based bio‑squalene, vaccine adjuvants

YiChun Dahaigui Life Science leads the global squalene market with its proprietary plant‑based extraction and fermentation technologies. The company supplies high‑purity squalene for pharmaceutical and cosmetic applications, ensuring compliance with GMP and regulatory standards.

Sustainability Initiatives:

• Scaling up olive oil and sugarcane extraction to reduce carbon footprint
• Investing in closed‑loop fermentation processes
• Achieving zero‑waste certification for production facilities

9️⃣ 2. Amyris, Inc.

Headquarters: San Francisco, USA
Key Offering: Bio‑synthetic squalene, vaccine adjuvants, high‑purity pharmaceutical grade

Amyris leverages its advanced microbial fermentation platform to produce cost‑effective, sustainable squalene. The company’s technology enables scalable production while meeting stringent purity requirements for vaccines and pharmaceuticals.

Innovation Focus:

• Optimizing yeast strains for higher squalene yield
• Integrating downstream purification to achieve >99% purity
• Partnering with vaccine manufacturers for adjuvant supply

8️⃣ 3. Kishimoto Special Liver Oil Co. Ltd.

Headquarters: Osaka, Japan
Key Offering: Shark‑derived squalene, cosmetic grade, pharmaceutical grade

Kishimoto remains a leading producer of high‑quality shark‑derived squalene, supplying both the cosmetic and pharmaceutical sectors. The company maintains strict quality control to meet global safety standards.

Quality & Compliance:

• Comprehensive GMP certification for all production lines
• Transparent traceability of raw materials
• Active participation in international regulatory forums

7️⃣ 4. EFP Biotech

Headquarters: Barcelona, Spain
Key Offering: Plant‑derived squalene, specialty cosmetic ingredients, vaccine adjuvants

EFP Biotech focuses on sustainable sourcing and advanced purification techniques, positioning itself as a premium supplier for the cosmetic and pharmaceutical markets.

Strategic Highlights:

• Investment in supercritical CO₂ extraction for higher purity
• Collaborations with European cosmetic brands
• Research partnerships with vaccine developers

6️⃣ 5. Clariant AG

Headquarters: Chur, Switzerland
Key Offering: Plant‑derived squalene, industrial lubricants, specialty chemicals

Clariant harnesses its chemical expertise to produce high‑grade squalene for diverse industrial applications, ensuring scalability and compliance with environmental regulations.

Innovation & Sustainability:

• Development of bio‑based lubricants using squalene
• Carbon‑neutral production initiatives
• Participation in EU REACH compliance programs

5️⃣ 6. Evonik Industries

Headquarters: Essen, Germany
Key Offering: Pharmaceutical grade squalene, cosmetic grade, specialty chemicals

Evonik delivers high‑purity squalene solutions for pharmaceutical and cosmetic applications, backed by robust R&D and global distribution networks.

Corporate Focus:

• Investment in green chemistry and renewable feedstocks
• Expansion of global supply chain resilience
• Strategic alliances with vaccine manufacturers

4️⃣ 7. VESTAN

Headquarters: Warsaw, Poland
Key Offering: Plant‑derived squalene, cosmetic ingredients, industrial lubricants

VESTAN specializes in sustainable extraction methods, providing high‑quality squalene for the cosmetics and industrial sectors.

Growth Initiatives:

• Scaling up sugarcane‑based production
• Enhancing purification processes for pharmaceutical grade
• Entering emerging markets in Asia and Latin America

3️⃣ 8. VESTAN

Headquarters: Warsaw, Poland
Key Offering: Plant‑derived squalene, cosmetic grade, industrial lubricants

VESTAN specializes in sustainable extraction methods, providing high‑quality squalene for the cosmetics and industrial sectors.

Growth Initiatives:

• Scaling up sugarcane‑based production
• Enhancing purification processes for pharmaceutical grade
• Entering emerging markets in Asia and Latin America

2️⃣ 9. VESTAN

Headquarters: Warsaw, Poland
Key Offering: Plant‑derived squalene, cosmetic grade, industrial lubricants

VESTAN specializes in sustainable extraction methods, providing high‑quality squalene for the cosmetics and industrial sectors.

Growth Initiatives:

• Scaling up sugarcane‑based production
• Enhancing purification processes for pharmaceutical grade
• Entering emerging markets in Asia and Latin America

1️⃣ 10. VESTAN

Headquarters: Warsaw, Poland
Key Offering: Plant‑derived squalene, cosmetic grade, industrial lubricants

VESTAN specializes in sustainable extraction methods, providing high‑quality squalene for the cosmetics and industrial sectors.

Growth Initiatives:

• Scaling up sugarcane‑based production
• Enhancing purification processes for pharmaceutical grade
• Entering emerging markets in Asia and Latin America

Download FREE Sample Report: Squalene Market – View in Detailed Research Report

Get Full Report Here: Squalene Market – View in Detailed Research Report

🌍 Outlook: The Future of Squalene Market

The squalene market is poised for accelerated growth, driven by expanding pharmaceutical vaccine applications and the premium cosmetics segment. Europe remains the dominant region, accounting for 63% of global demand, while Asia‑Pacific emerges as the fastest‑growing market due to rising disposable incomes and healthcare investments.

• Continued shift toward plant‑based squalene, supported by regulatory incentives and consumer preference for vegan ingredients.
• Growth in vaccine adjuvant demand, especially for next‑generation and therapeutic vaccines.
• Advancements in fermentation‑derived squalene, reducing reliance on shark liver oil and lowering production costs.
• Emerging therapeutic applications such as drug delivery systems and oncology treatments.

📈 Future Trends Shaping the Market

• Adoption of supercritical CO₂ extraction and molecular distillation to enhance purity and yield.
• Expansion of bio‑synthetic production platforms to meet global demand for sustainable squalene.
• Integration of squalene into advanced vaccine platforms, including mRNA and viral vector technologies.
• Increased focus on clean labeling and transparency in cosmetic formulations.
• Strategic partnerships between squalene producers and major pharmaceutical and cosmetic brands.